Sarcopenia and cachexia: the adaptations of negative regulators of skeletal muscle mass
Open accessThe DOI matches its Crossref record; 259 of the 261 references it cites were found in a registry or an index.
Abstract
Recent advances in our understanding of the biology of muscle, and how anabolic and catabolic stimuli interact to control muscle mass and function, have led to new interest in the pharmacological treatment of muscle wasting. Loss of muscle occurs as a consequence of several chronic diseases (cachexia) as well as normal aging (sarcopenia). Although many negative regulators [Atrogin-1, muscle ring finger-1, nuclear factor-kappaB (NF-κB), myostatin, etc.] have been proposed to enhance protein degradation during both sarcopenia and cachexia, the adaptation of mediators markedly differs among these conditions. Sarcopenic and cachectic muscles have been demonstrated to be abundant in myostatin- and apoptosis-linked molecules. The ubiquitin-proteasome system (UPS) is activated during many different types of cachexia (cancer cachexia, cardiac heart failure, chronic obstructive pulmonary disease), but not many mediators of the UPS change during sarcopenia. NF-κB signaling is activated in cachectic, but not in sarcopenic, muscle. Some studies have indicated a change of autophagic signaling during both sarcopenia and cachexia, but the adaptation remains to be elucidated. This review provides an overview of the adaptive changes in negative regulators of muscle mass in both sarcopenia and cachexia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Namely, the circulating levels of microbiota-derived indoxyl sulfate are positively associated with the expression of myostatin and atrogin-1 [29], representing two of the main negative regulators of skeletal muscle mass [30].”
From Gut Microbiota, Muscle Mass and Function in Aging: A Focus on Physical Frailty and Sarcopenia (2019) · cites this paper as [30]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Wenz, T., Rossi, S. G., Rotundo, R. L., Spiegelman, B. M., & Moraes, C. T. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911570106 · Cited by 600 · cited 2×
“[111] recognized a”
RetractedMariño, G., Urı́a, J. A., Puente, X. S., Quesada, V., Bordallo, J., & López-Otı́n, C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208247200 · Cited by 208
RetractedRepertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y.-J., Jiang, Q., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,304
Cui, C., Cui, J., Jin, F., Cui, Y., Li, R., Jiang, X., Tian, Y., Wang, K., Jiang, P., & Gao, J. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479571 · Cited by 5,203
Danial, N. N., & Korsmeyer, S. J. (2004) · Cell · doi:10.1016/s0092-8674(04)00046-7 · Cited by 4,651
Pankiv, S., Clausen, T. H., Lamark, T., Brech, A., Bruun, J.-A., Outzen, H., Øvervatn, A., Bjørkøy, G., & Johansen, T. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702824200 · Cited by 4,578 · cited 1×
“p62/SQSTM1 interacts with the autophagosome membrane microtubule-associated protein light chain (LC3) protein which facilitates the delivery of its polyubiquitinated cargo for lysosomal degradation [101, 102].”
BackgroundThe Ubiquitin-Proteasome Proteolytic Pathway: Destruction for the Sake of Construction
Glickman, M. H., & Ciechanover, A. (2002) · Physiological Reviews · doi:10.1152/physrev.00027.2001 · Cited by 4,237
Levine, B., & Klionsky, D. J. (2004) · Developmental Cell · doi:10.1016/s1534-5807(04)00099-1 · Cited by 3,678
Identification of ubiquitin ligases required for skeletal muscle atrophy.
Bodine, S. C., Latres, E., Baumhueter, S., Lai, V. K.-M., Nunez, L., Clarke, B. A., Poueymirou, W. T., Panaro, F. J., Na, E., Dharmarajan, K., et al. (2001) · Science · doi:10.1126/science.1065874 · Cited by 3,521 · cited 2×
“improved knowledge of the regulation of the ubiquitin– proteasome system in skeletal muscle [47].”
BackgroundBjørkøy, G., Lamark, T., Brech, A., Outzen, H., Perander, M., Øvervatn, A., Stenmark, H., & Johansen, T. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200507002 · Cited by 3,276 · cited 1×
“p62/SQSTM1 interacts with the autophagosome membrane microtubule-associated protein light chain (LC3) protein which facilitates the delivery of its polyubiquitinated cargo for lysosomal degradation [101, 102].”
Background
Research works printed but not linked: 3
- Roubenoff R Hughes VA Sarcopenia: current concepts J Gerontol A Biol Sci Med Sci 2000 55 M716 M724 10.1093/gerona/55.12.M716 11129393 · DOI · Paper page
- Sakuma K, Yamaguchi A (2011) Sarcopenia: molecular mechanisms and current therapeutic strategy. In: Perloft JW, Wong AH (eds) Cell aging. Nova Science, New York (in press)
- Moresi V Pristera A Scicchitano BM Molinaro M Teodori L Sassoon D Tumor necrosis factor-α inhibition of skeletal muscle regeneration is mediated by a caspase-dependent stem cell response Stem Cells 2008 26 997 11008 10.1634/stemcells.2007-0493 18258721 · DOI · Paper page
Cited by
Quality of Life in Sarcopenia and Frailty
Rizzoli, R., Reginster, J.-Y., Arnal, J.-F., Bautmans, I., Beaudart, C., Bischoff-Ferrari, H., Biver, E., Boonen, S., Brandi, M.-L., Chines, A., et al. (2013) · Calcified Tissue International · doi:10.1007/s00223-013-9758-y · Cited by 425
“inflammatory conditions)[50].”
Mitochondria and ageing: Role in heart, skeletal muscle and adipose tissue
Boengler, K., Kosiol, M., Mayr, M., Schulz, R., & Rohrbach, S. (2017) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12178 · Cited by 421
Gut Microbiota, Muscle Mass and Function in Aging: A Focus on Physical Frailty and Sarcopenia
Ticinesi, A., Nouvenne, A., Cerundolo, N., Catania, P., Prati, B., Tana, C., & Meschi, T. (2019) · Nutrients · doi:10.3390/nu11071633 · Cited by 418
“Namely, the circulating levels of microbiota-derived indoxyl sulfate are positively associated with the expression of myostatin and atrogin-1 [29], representing two of the main negative regulators of skeletal muscle mass [30].”
BackgroundLee, Y., Kim, S. U., Song, K., Park, J. Y., Kim, D. Y., Ahn, S. H., Lee, B., Kang, E. S., Cha, B., & Han, K. (2016) · Hepatology · doi:10.1002/hep.28376 · Cited by 340
Wakabayashi, H., & Sakuma, K. (2014) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1007/s13539-014-0162-x · Cited by 334
Self-citation
Metadata
- Authors
- Sakuma, K., & Yamaguchi, A.
- Affiliations
- Toyohashi University of Technology (JP)
- Health Sciences University of Hokkaido (JP)
- Corresponding author
- Sakuma, Kunihiro
- Venue
- Journal of Cachexia Sarcopenia and Muscle
- Publisher
- Wiley
- Published
- 2012-01-12
- Volume
- 3
- Issue
- 2
- Pages
- 77-94
- ISSN
- 2190-5991 (ISSN-L)
- 2190-6009
- PMC
- PMC3374017
- OpenAlex
- W2079792861
- Cited by
- 137
- References
- 261
- Citations by year
- 2026: 2 · 2025: 12 · 2024: 7 · 2023: 7 · 2022: 9 · 2021: 10 · 2020: 5 · 2019: 6 · 2018: 11 · 2017: 11 · 2016: 7 · 2015: 11 · 2014: 15 · 2013: 21 · 2012: 3
- FWCI
- 6.42
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Cachexia Sarcopenia and Muscle (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- Japan Society for the Promotion of Science (23500778)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Health Sciences › Nursing › Nutrition and Dietetics › Muscle metabolism and nutrition
- Keywords
- sarcopenia, cachexia, muscle atrophy, skeletal muscle mass, atrogin-1, MuRF1, NF-κB signaling, myostatin, ubiquitin-proteasome system, apoptosis, autophagy, protein degradation, aging, cancer cachexia, heart failure, chronic obstructive pulmonary disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Sarcopenia and cachexia: the adaptations of negative regulators of skeletal muscle mass. https://app.cochat.ai/papers/10.1007/s13539-011-0052-4
- The paper
- Sakuma, K., & Yamaguchi, A. (2012). Sarcopenia and cachexia: the adaptations of negative regulators of skeletal muscle mass. Journal of Cachexia Sarcopenia and Muscle. https://doi.org/10.1007/s13539-011-0052-4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.